Adam Williams | Director, mRNA Commercial Strategy
Pfizer

Adam Williams is currently Director, mRNA Commercial Strategy & Innovation at Pfizer, leading strategic efforts in global pandemic security, planning for a broad array of defenses, and driving Pfizer’s thought leadership in preparedness. Adam previously led strategy and market intelligence at CSL Seqirus, including global, cross-functional commercial strategy projects, competitive intelligence, market research, and new product planning. Previously he led the immunization practice at Rabin Martin, a global health consultancy focused on public health policies and programs, and focused on introduction of new vaccines in low- and middle-income countries with the Clinton Health Access Initiative (CHAI) and Axios International. Adam holds a Master of Science in Public Health (MSPH) with a concentration in Global Disease Epidemiology and Control (GDEC) from the Johns Hopkins Bloomberg School of Public Health and a BSc/BA, Biochemistry/Biology from the University of Virginia.